Visitor information – Everything you need to know about visiting our sites.
Alfred Health research outcomes are published in a wide range of peer reviewed journals.
Search or browse research publications by year, research area, publication type or keyword.
Publication Details
How I treat acute myeloid leukemia in the era of new drugs
DiNardo CD, Wei AH
(2020), Blood, 135(2), 85-96
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
DiNardo CD, Jonas BA, Pullarkat V, Thirman MJ, Garcia JS, Wei AH, Konopleva M, Döhner H, Letai A, Fenaux P, Koller E, Havelange V, Leber B, Esteve J, Wang J, Pejsa V, Hájek R, Porkka K, Illés Á, Lavie D, Lemoli RM, Yamamoto K, Yoon SS, Jang JH, Yeh SP, Turgut M, Hong WJ, Zhou Y, Potluri J, Pratz KW
(2020), NEW ENGL J MED, 383(7), 617-29
notuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemia
Ryland GL, Barraclough A, Fong CY, Fleming S, Bajel A, Hofmann O, Westerman D, Grimmond S, Blombery P
(2020), Brit J Haematol, 191(1), 123-6
DOI: 10.1111/bjh.16949
Cotargeting BCL-2 and MCL-1 in high-risk B-ALL
Moujalled DM, Hanna DT, Hediyeh-Zadeh S, Pomilio G, Brown L, Litalien V, Bartolo R, Fleming S, Chanrion M, Banquet S, Maragno AL, Kraus-Berthier L, Schoumacher M, Mullighan CG, Georgiou A, White CA, Lessene G, Huang DCS, Roberts AW, Geneste O, Rasmussen L, Davis MJ, Ekert PG, Wei A, Ng AP, Khaw SL
(2020), Blood Adv, 4(12), 2762-7
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate®): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup
Chelle P, Yeung CHT, Croteau SE, Lissick J, Balasa V, Ashburner C, Park YS, Bonanad S, Megías-Vericat JE, Nagao A, Wynn T, Corrales-Medina F, Tran H, Sharathkumar A, Chitlur M, Sarmiento S, Edginton A, Iorio A
(2020), Clin Pharmacokinet, 59(2), 245-56
The Australian experience with switching to extended half-life factor VIII and IX concentrates: On behalf of the Australian Haemophilia Centre Directors' Organisation
Brennan Y, Parikh S, McRae S, Tran H
(2020), Haemophilia, 26(3), 529-35
DOI: 10.1111/hae.13970
Incidence of residual perfusion defects by lung scintigraphy in patients treated with rivaroxaban compared with warfarin for acute pulmonary embolism
Lim MS, Nandurkar D, Jong I, Cummins A, Tran H, Chunilal S
(2020), J THROMB THROMBOLYS, 49(2), 220-7
Risk Stratification of Acute Pulmonary Embolism and Determining the Effect on Chronic Cardiopulmonary Complications: The REACH Study
Stevens H, Fang W, Clements W, Bloom J, McFadyen J, Tran H
(2020), TH Open, 40(1), e45-50
Ischaemic stroke and transient ischaemic attack on anticoagulants: outcomes in the era of direct oral anticoagulants
Valente M, Leung S, Wu P, Oh DH, Tran H, Choi PMC
(2020), Intern Med J, 50(1), 110-3
DOI: 10.1111/imj.14652
Predicting the Risk of Recurrent Venous Thromboembolism: Current Challenges and Future Opportunities
Stevens H, Peter K, Tran H, McFadyen J
(2020), J Clin Med, 9(5), 1582
DOI: 10.3390/jcm9051582
Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment
Jang SM, Bahjri K, Tran H
(2020), Pharmacy (Basel), 8(1), 30
Interlaboratory validation of apixaban levels in ex vivo patient samples using a chromogenic anti-factor Xa assay
Singh J, Ong DM, Ling V, Lim MS, Malan E, Servadei P, Wallis A, Kelsey G, Chunilal S, Tran H
(2020), Int J Lab Hematol, 42(1), e23-6
Metastatic melanoma presenting as intravenous tumour thrombus
Nguyen J, Clements W, McLean C, Haydon A, Moore M, Yap KS, Mar V, Shackleton M
(2020), J MED IMAG RADIAT ON, 64(6), 814-6
Characterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities
Cho, Steven X.; Rudloff, Ina; Lao, Jason C.; Pang, Merrin A.; Goldberg, Rimma; Bui, Christine B.; McLean, Catriona A.; Stock, Magdalena; Klassert, Tilman E.; Slevogt, Hortense; Mangan, Niamh E.; Cheng, Wei; Fischer, Doris; Gfroerer, Stefan; Sandhu, Manjee
(2020), NAT COMMUN, 11(1), 5794
A 40-Year-Old Man with Persistent Febrile Neutropenia and Subsequent Rash
Meher-Homji, Zaal; North, Daniel; Stewart, James D.; Moir, Diana; Kalff, Anna; Fleming, Shaun; Ananda-Rajah, Michelle R.; Fuller, Andrew; Morrissey, C. Orla
(2020), CLIN INFECT DIS, 71(12), 3260-3262.
DOI: 10.1093/cid/ciaa562
Diagnostic testing for COVID-19
Griffin, David W.J.; Bramwell, Eliza; Cheng, Allen C.; Spelman, Denis W.
(2020), INTERN MED J, 50(12), 1594-1595.
DOI: 10.1111/imj.15083
RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML
Brown, Anna L.; Arts, Peer; Carmichael, Catherine L.; Babic, Milena; Dobbins, Julia; Chong, Chan Eng; Schreiber, Andreas W.; Feng, Jinghua; Phillips, Kerry; Wang, Paul P.S.; Ha, Thuong; Homan, Claire C.; King-Smith, Sarah L.; Rawlings, Lesley; Vakulin, Ca
(2020), BLOOD ADV, 4(6), 1131-1144.
Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML
DiNardo, C. D.; Tiong, I. S.; Quaglieri, A.; MacRaild, S.; Loghavi, S.; Brown, F. C.; Thijssen, R.; Pomilio, G.; Ivey, A.; Salmon, J. M.; Glytsou, C.; Fleming, S. A.; Zhang, Q.; Ma, H.; Patel, K. P.; Kornblau, S. M.; Xu, Z.; Chua, C. C.; Chen, Xufeng; Blo
(2020), BLOOD, 135(11), 791-803.
Clinical acceleration of jak2 p.v617f driven myeloproliferative disease due to a new uncommon homozygous mpl p.y591d mutation
Ong, Jeremy; Lin, Jane I.; Mitchell, Helen; Morgan, Susan; Perkins, Andrew C.
(2020), HAEMATOLOGICA, 105(8), E428-E431.
Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT)
Chua, Chong Chyn; Roberts, Andrew W.; Reynolds, John; Fong, Chun Yew; Ting, Stephen B.; Salmon, Jessica M.; MacRaild, Sarah; Ivey, Adam; Tiong, Ing Soo; Fleming, Shaun; Brown, Fiona C.; Loo, Sun; Majewski, Ian J.; Bohlander, Stefan K.; Wei, Andrew H.
(2020), J CLIN ONCOL, 38(30), 3506-3517.
DOI: 10.1200/JCO.20.00572